Unlocking NGS and Regulatory Synergy in GCT for Maximum Impact
NGS for Product Characterization in CGT: Biosafety and Genome Integrity
From Science to Compliance: Effective Validation of Genedata Selector
Discover What’s New in Genedata Screener 2026
Japan: Cutting Days from the DMTA Cycle in Discovery Research
Genedata Selector Product Development Roadmap
Japan: Driving Next-Generation Discovery with Organoids
Japan: Increasing Efficiency of Antibody Discovery and Engineering Workflows
Japan: Utilizing Genedata Biologics’ Versatility for Cloud Software Integrations
Therapeutic Antibody Profiling with Genedata Biologics — AI & ML Framework for Cancer Drug Discovery
Towards MAM in QC: Accelerating Adoption with Streamlined Data Analysis Strategies
Merck: Accelerating Precision Medicine: Using AI Assistants in GxP Environments
Exploring an AI-Native Approach to Antibody Discovery
Lessons Learned from a Global Genedata Deployment: Impact on Automation, Novel Modalities, and AI/ML
Image Analysis with Machine Learning (ML) at Arvinas
Data, Data in the Well: Who’s the FAIRest of them all? A Tale of In Vitro Characterization of Biologics Preparing for the AI Era
Japan: Enterprise Analytics Platform for Biopharma Mass Spectrometry
Japan: Integrated Data Management for Multi-Modality Drug Development
Rapid Contamination Identification with Nanopore Sequencing
Automating Adventitious Agent Detection for GMP and Lot Release
Merck: Automating the DMTA Cycle for Faster Drug Discovery
Powering HT Protein Expression and Purification
A Multiplexed Platform for Covalent Ligand Screening
Democratizing NGS Analysis for Cell Line Development
Japan: Biopharma Discovery DX
Integrating Wet & Digital Labs to Accelerate Biologics Discovery
Fireside Chat: RNA Therapeutics & Data Innovation
Automating Data Analysis of High-Throughput RNA-Seq
Automating Data Analysis in Oligo Screening
Evotec’s Oligo Discovery: AI Design & RT-qPCR Screening
Data-Driven Oligonucleotide Discovery in RNAHub
Chemical Liability Screening for Biotherapeutic Protein Discovery
Digitalizing mRNA Workflows for Vaccines and Therapeutics
Enabling MS-Based MAM in QC Through a Robust New Peak Detection Workflow
Merck: X-Omics Platform Accelerates Precision Medicine
Journey to Validated NGS In-House
Japan: DX Platform for Increasing Success Rates in Pharma R&D
What’s New in Genedata Screener 2025
Accelerating RNA Drug Discovery with Automated Data Analysis
Enhancing Biotherapeutic Data Management at Zoetis
